Stay updated with breaking news from Microscopic Polyangiitis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The global Eosinophilic Granulomatosis With Polyangiitis Treatment Market is currently valued at US$ 173.8 Million in 2023 and is anticipated to expand at a CAGR of 5.2%. Owing to the technological advances in healthcare the market is likely to propel to US$ 288.5 Million by 2033.The growing occurrences of churg str...
Microscopic polyangitis, infection of small blood vessels, presents with general symptoms of fever, muscle pain and weight loss. Localized symptoms can also occur.
Survey respondents described generally poor health-related quality of life (QoF) that was characterized as being more severe with a skin-specific instrument than with a generic health-related QoF index.
In 2023, Eosinophilic Granulomatosis with Polyangiitis Treatment Market is expected to reach a value of US$ 173.8 million at a CAGR of 5.2%. Healthcare technology advancements are expected to drive the market to US$ 288.5 million by 2033.The growing occurrences of churg strauss syndrome and other allergic reactions...
PALM BEACH, Fla., June 7, 2022 /PRNewswire/ -- FinancialNewsMedia.com News Commentary - The global Central Nervous System (CNS) treatments and its market revenues had been steadily growing pre-pandemic